Pregnancy-associated plasma protein A in non-cardiac conditions

Clinical Biochemistry

Volumn 41, Issue 7-8, 2008, Pages 548-553

  Iversen, Kasper Karmark ^a   Teisner, Ane Sogaard ^b   Teisner, Borge ^c   Kliem, Anette ^d   Bay, Morten ^a   Kirk, Vibeke ^a   Nielsen, Henrik ^b   Boesgaard, Soren ^a   Grande, Peer ^a   Clemmensen, Peter ^a  

^a Rigshospitalet   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

^c London Bridge Fertility   (United Kingdom)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Coronary artery disease; Non cardiac conditions; Pregnancy associated plasma protein A; Specificity

Indexed keywords

PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; ELECTROCARDIOGRAM; FEMALE; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL;

ADULT; AGED; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A;

EID: 41849101012     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.01.012     Document Type: Article

References (40)

1. Bayes-Genis A., Conover C.A., Overgaard M.T., Bailey K.R., Christiansen M., Holmes Jr. D.R., et al. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med 345 (2001) 1022-1029
2. Aso Y., Okumura K., Wakabayashi S., Takebayashi K., Taki S., and Inukai T. Elevated pregnancy-associated plasma protein-a in sera from type 2 diabetic patients with hypercholesterolemia: associations with carotid atherosclerosis and toe-brachial index. J Clin Endocrinol Metab 89 (2004) 5713-5717
3. Ceska R., Stulc T., Zima T., Malbohan I., and Fialova L. PAPP-A, a novel marker of unstable plaque, is not influenced by hypolipidemic treatment in contrast to CRP. Atherosclerosis 166 (2003) 195-196
4. Conti E., Andreotti F., and Zuppi C. Pregnancy-associated plasma protein a as predictor of outcome in patients with suspected acute coronary syndromes. Circulation 109 (2004) e211-e212
5. Cosin-Sales J., Christiansen M., Kaminski P., Oxvig C., Overgaard M.T., Cole D., et al. Pregnancy-associated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris. Circulation 109 (2004) 1724-1728
6. Cosin-Sales J., Kaski J.C., Christiansen M., Kaminski P., Oxvig C., Overgaard M.T., et al. Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris. Eur Heart J 26 (2005) 2093-2098
7. Crea F., and Andreotti F. Pregnancy associated plasma protein-A and coronary atherosclerosis: marker, friend, or foe?. Eur Heart J 26 (2005) 2075-2076
8. Elesber A.A., Conover C.A., Denktas A.E., et al. Prognostic value of circulating pregnancy-associated plasma protein levels in patients with chronic stable angina. Eur Heart J 27 (2006) 1678-1684
9. Futterman L.G., and Lemberg L. Novel markers in the acute coronary syndrome: BNP, IL-6, PAPP-A. Am J Crit Care 11 (2002) 168-172
10. Heeschen C., Dimmeler S., Hamm C.W., Fichtlscherer S., Simoons M.L., and Zeiher A.M. Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. J Am Coll Cardiol 45 (2005) 229-237
11. Khosravi J., Diamandi A., Krishna R.G., Bodani U., Mistry J., and Khaja N. Pregnancy associated plasma protein-A: ultrasensitive immunoassay and determination in coronary heart disease. Clin Biochem 35 (2002) 531-538
12. Laterza O.F., Cameron S.J., Chappell D., Sokoll L.J., and Green G.B. Evaluation of pregnancy-associated plasma protein A as a prognostic indicator in acute coronary syndrome patients. Clinca Chimica Acta 348 (2004) 163-169
13. Liu J.L., Zhang H., Xie X.J., Chen L., and Zhao C.L. Changes of pregnancy-associated plasma protein-A in patients with acute coronary syndrome. Chin Med J (Engl) 118 (2005) 1827-1829
14. Lund J., Qin Q.P., Ilva T., Pettersson K., Voipio-Pulkki L.M., Porela P., and Pulkki K. Circulating pregnancy-associated plasma protein a predicts outcome in patients with acute coronary syndrome but no troponin I elevation. Circulation 108 (2003) 1924-1926
15. Lund J., Qin Q.P., Ilva T., Nikus K., Eskola M., Porela P., et al. Pregnancy-associated plasma protein A: a biomarker in acute ST-elevation myocardial infarction (STEMI). Ann Med 38 (2006) 221-228
16. Qin Q.P., Laitinen P., Majamaa-Voltti K., Eriksson S., Kumpula E.K., and Pettersson K. Release patterns of pregnancy associated plasma protein A (PAPP-A) in patients with acute coronary syndromes. Scand Cardiovasc J 36 (2002) 358-361
17. Bassand J.P., Hamm C.W., Ardissino D., Boersma E., Budaj A., Fernandez-Aviles F., et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. The task force for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the European Society of Cardiology. Eur Heart J 28 (2007) 1598-1660
18. Aso Y., Okumura K., Wakabayashi S., Takebayashi K., Taki S., and Inukai T. Elevated pregnancy-associated plasma protein-a in sera from type 2 diabetic patients with hypercholesterolemia: associations with carotid atherosclerosis and toe-brachial index. J Clin Endocrinol Metab 89 (2004) 5713-5717
19. Fialova L., Pileckova N., Bauer J., Soukupova J., Kalousova M., Malbohan I., et al. Pregnancy-associated plasma protein-A in patients with cerebrovascular diseases-a pilot study. Prague Med Rep 107 (2006) 37-45
20. Westergaard J.G. Studies on pregnancy associated plasma protein-A (PAPP-A) in normal and abnormal pregnancy (1987)
21. Bay M., Kirk V., Parner J., Hassager C., Nielsen H., Krogsgaard K., et al. NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function. Heart 89 (2003) 150-154
22. Karl J., Borgya A., Gallusser A., Huber E., Krueger K., Rollinger W., and Schenk J. Development of a novel, N-terminal-proBNP (NT-proBNP) assay with a low detection limit. Scand J Clin Lab Invest Suppl 230 (1999) 177-181
23. Kirk V., Bay M., Parner J., Krogsgaard K., Herzog T.M., Boesgaard S., et al. N-terminal proBNP and mortality in hospitalised patients with heart failure and preserved vs. reduced systolic function: data from the prospective Copenhagen Hospital Heart Failure study (CHHF). Eur J Heart Fail 6 (2004) 335-341
24. Andersen D.C., Koch C., Jensen C.H., Skjødt K., Brandt J., and Teisner B. High prevalence of human anti-bovine IgG antibodies as the major cause of false positive reactions in two-site immunoassays based on monoclonal antibodies. J Immunoassay Immunochem 1 (2004) 17-30
25. Rossen M., Iversen K., Teisner A., Teisner B., Kliem A., and Grudzinskas G. Optimisation of sandwich ELISA based on monoclonal antibodies for the specific measurement of pregnancy-associated plasma protein (PAPP-A) in acute coronary syndrome. Clin Biochem 40 (2007) 478-484
26. Khan I.A., Wattanasuwan N., Mehta N.J., Tun A., Singh N., Singh H.K., et al. Prognostic value of serum cardiac troponin I in ambulatory patients with chronic renal failure undergoing long-term hemodialysis: a two-year outcome analysis. J Am Coll Cardiol 38 (2001) 991-998
27. Roppolo L.P., Fitzgerald R., Dillow J., Ziegler T., Rice M., and Maisel A. A comparison of troponin T and troponin I as predictors of cardiac events in patients undergoing chronic dialysis at a Veteran's Hospital: a pilot study. J Am Coll Cardiol 34 (1999) 448-454
28. James P., Ellis C.J., Whitlock R.M., McNeil A.R., Henley J., and Anderson N.E. Relation between troponin T concentration and mortality in patients presenting with an acute stroke: observational study. BMJ 320 (2000) 1502-1504
29. Trooyen M., Indredavik B., Rossvoll O., and Slordahl S.A. Myocardial injury in acute stroke assessed by troponin I. Tidsskr Nor Laegeforen 121 (2001) 421-425
30. Pateron D., Beyne P., Laperche T., Logeard D., Lefilliatre P., Sogni P., et al. Elevated circulating cardiac troponin I in patients with cirrhosis. Hepatology 29 (1999) 640-643
31. Missov E., Calzolari C., and Pau B. Circulating cardiac troponin I in severe congestive heart failure. Circulation 96 (1997) 2953-2958
32. Setsuta K., Seino Y., Takahashi N., Ogawa T., Sasaki K., Harada A., et al. Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure. Am J Cardiol 84 (1999) 608-611 A9
33. Missov E., Calzolari C., Davy J.M., Leclercq F., Rossi M., and Pau B. Cardiac troponin I in patients with hematologic malignancies. Coron Artery Dis 8 (1997) 537-541
34. Spies C., Haude V., Fitzner R., Schroder K., Overbeck M., Runkel N., and Schaffartzik W. Serum cardiac troponin T as a prognostic marker in early sepsis. Chest 113 (1998) 1055-1063
35. Ammann P., Fehr T., Minder E.I., Gunter C., and Bertel O. Elevation of troponin I in sepsis and septic shock. Intensive Care Med 27 (2001) 965-969
36. Coskun A., Bicik Z., Duran S., Alcelik A., Soypacaci Z., Yavuz O., and Oksuz S. Pregnancy-associated plasma protein A in dialysis patients. Clin Chem Lab Med 45 (2007) 63-66
37. Sinosich M.J., Teisner B., Folkersen J., Saunders D.M., and Grudzinskas J.G. Radioimmunoassay for pregnancy-associated plasma protein A. Clin Chem 28 (1982) 50-53
38. Andersen D.C., and Reilly D.E. Production technologies for monoclonal antibodies and their fragments. Curr Opin Biotechnol 15 (2004) 456-462
39. Qin Q.P., Kokkala S., Lund J., Tamm N., Qin X., Lepantalo M., and Pettersson K. Immunoassays developed for pregnancy-associated plasma protein-A (PAPP-A) in pregnancy may not recognize PAPP-A in acute coronary syndromes. Clin Chem 52 (2006) 398-404
40. Wittfooth S., Qin Q.P., Lund J., Tierala I., Pulkki K., Takalo H., and Pettersson K. Immunofluorometric point-of-care assays for the detection of acute coronary syndrome-related noncomplexed pregnancy-associated plasma protein A. Clin Chem 52 (2006) 1794-1801